Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baptist Gallwitz

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
Herz|May 15, 2010
[Incretins: do they exert cardiovascular effects?]Baptist Gallwitz
MMW Fortschritte Der Medizin|November 9, 2016
[Therapy with oral antidiabetic drugs]Baptist Gallwitz
Current Opinion in Endocrinology, Diabetes, and Obesity|December 26, 2015
Glucagon-like peptide-1 and gastric inhibitory polypeptide: new advancesBaptist Gallwitz
Innere Medizin (Heidelberg, Germany)|August 21, 2024
[Drug therapy of type-2-diabetes-is metformin dispensable now?]Baptist Gallwitz
Deutsche Medizinische Wochenschrift (1946)|August 12, 2006
[Lipohypertrophy]Karsten Müssig, Baptist Gallwitz
Medizinische Klinik (Munich, Germany : 1983)|August 26, 2003
[Normalization of blood pressure and lipids in patients with diabetes]Andreas Clemens, Baptist Gallwitz
The Review of Diabetic Studies : RDS|January 21, 2012
The continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS special issueItamar Raz, Baptist Gallwitz
Frontiers in Endocrinology|July 16, 2021
Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of SemaglutideBaptist Gallwitz, Francesco Giorgino
Deutsche Medizinische Wochenschrift (1946)|November 17, 2006
[Primary adrenal cortical insufficiency (Addison's disease)]Karsten Müssig, Baptist Gallwitz
Best Practice & Research. Clinical Endocrinology & Metabolism|September 15, 2009
Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)Nancy A Thornberry, Baptist Gallwitz
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
Herz|May 15, 2010
[Incretins: do they exert cardiovascular effects?]Baptist Gallwitz
MMW Fortschritte Der Medizin|November 9, 2016
[Therapy with oral antidiabetic drugs]Baptist Gallwitz
Current Opinion in Endocrinology, Diabetes, and Obesity|December 26, 2015
Glucagon-like peptide-1 and gastric inhibitory polypeptide: new advancesBaptist Gallwitz
Innere Medizin (Heidelberg, Germany)|August 21, 2024
[Drug therapy of type-2-diabetes-is metformin dispensable now?]Baptist Gallwitz
Deutsche Medizinische Wochenschrift (1946)|August 12, 2006
[Lipohypertrophy]Karsten Müssig, Baptist Gallwitz
Medizinische Klinik (Munich, Germany : 1983)|August 26, 2003
[Normalization of blood pressure and lipids in patients with diabetes]Andreas Clemens, Baptist Gallwitz
The Review of Diabetic Studies : RDS|January 21, 2012
The continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS special issueItamar Raz, Baptist Gallwitz
Frontiers in Endocrinology|July 16, 2021
Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of SemaglutideBaptist Gallwitz, Francesco Giorgino
Deutsche Medizinische Wochenschrift (1946)|November 17, 2006
[Primary adrenal cortical insufficiency (Addison's disease)]Karsten Müssig, Baptist Gallwitz
Best Practice & Research. Clinical Endocrinology & Metabolism|September 15, 2009
Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)Nancy A Thornberry, Baptist Gallwitz
Pageof 13